Eurofins Animal Health Testing Announces Relocation to State-of-the-Art Facility
August 19, 2021
Eurofins Animal Health Testing Announces Relocation to State-of-the-Art Facility
Eurofins Animal Health Testing is pleased to announce relocation of its 21 CFR part 225/226-compliant cGMP and 21 CFR Part 58-compliant GLP testing laboratory from its legacy facility at 671 S. Meridian Rd, Greenfield, Indiana to a new, state-of-the-art 11,000 square-foot laboratory at 9550 Zionsville Rd., Suite 9, Indianapolis, Indiana,46268.
Our relocation was successful and executed as planned; the laboratory network and instruments were brought back online after only a three-business-day service interruption. We immediately began qualifications for instruments and critical equipment, and remaining critical and ancillary equipment qualifications will be completed over the next few weeks. Critical services such as nitrogen gas, deionized water, and electrical have been tested, verified and approved for laboratory use.
“We are thrilled to be in a facility that was purpose-built for receiving, processing and testing samples containing both high and low levels of animal feed additives. Supporting the developers and regulators of animal feed products is an essential part of preserving a safe and reliable supply chain, and we are prepared for the challenges to meet these critical needs. There is also an exciting opportunity for reorganization and refinements to support improvements to daily operations which ultimately will allow us to better serve our clients’ needs. We’re excited to discuss opportunities for collaboration or to arrange a site visit for our current and potential clientele,” stated Business Unit Manager Todd Seifert.
About Eurofins Animal Health Testing:
- Performs cGMP-compliant chemical feed assays and GLP-compliant feed and tissue testing for:
- Pharma
- Medicated Feed Production Facilities
- Test sites
- Universities
- CROs
- Routinely performs analysis of medicated animal products to determine the concentration of veterinary drugs including:
- Ractopamine
- Nicarbazin
- Monensin
- Oxytetracycline
- Salinomycin
- Lasalocid
- Chlortetracycline
- Narasin
- Tilmicosin
- Tylosin
- Is capable of performing any chemical analysis for veterinary drug content in edible tissues, feed and feed ingredients utilizing validated internally developed and standard methods of analysis.
- Complies with US FDA regulations for cGMP-compliant animal product testing, GLP studies and maintains ISO 17025 accreditations.
Eurofins Animal Health Facility Highlights:
- Personnel
- Staff Scientists
- Study Directors/
Principal Investigators (GLP)
- Quality Assurance Unit
- Chemical Lab Analysts
- Chemical Lab Technicians
- Sample Registration
- Sample Management
- Study Coordinators
- Stability Storage
- -80°C
- -20°C
- 5°C
- Laboratory Ambient
- 25°C/60%RH
- 30°C/65%RH
- 40°C/75%RH
- Other Custom Conditions Available
- Physically separated sample preparation and analysis laboratory areas
- Tissue and non-medicated ingredients and finished feeds
- Type B and Type C medicated animal products
- Instrumentation
- 12 HPLCs with capability of analysis utilizing UV, fluorescence, and PCD-Vis
- 6 LC-MS/MS systems suitable for the analysis of samples containing animal feed additives ranging in concentration from ppm to ppt.
- GC-FID for analysis of volatile additives
- Schaefer Technologies Autoturb System
- Infrastructure
- New local IT network
- Cummins backup power generator
- Centrally located in the heart of US agriculture in Northwest Indianapolis for convenience servicing animal health industry stakeholders
To learn more, please visit: AnimalHealth.EurofinsUS.com
For Questions or testing inquiries please call +1 (317) 315-2211, or email EurofinsAnimalHealth@eurofinsUS.com.
About Eurofins – the global leader in bio-analysis
Eurofins is Testing for Life. Eurofins is the global leader in food, environment, and pharmaceutical product testing. It is also one of the market leaders in testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and has a rapidly developing presence in highly specialised and molecular clinical diagnostic testing.
With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.